Should you buy Tenet Healthcare stock now?
Yes, the technical signal for Tenet Healthcare is currently Strong Buy. Tenet Healthcare trades at $286.03 as of Nov 14, 2026. The technical analysis shows the following: MACD is positive (bullish trend) at 6.524 with rising momentum (signal: 5.446); RSI is at 58.7 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $306.18 points to 7.0% upside. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for Tenet Healthcare stock?
The average analyst price target for Tenet Healthcare is $306.18. The current price is $286.03, which gives an upside of 7.0%. Based on this, the stock is considered fairly valued. The fair value range (±10% of the price target) is between $275.56 and $336.80.
Is Tenet Healthcare a dividend stock?
No, Tenet Healthcare does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Tenet Healthcare stock?
Tenet Healthcare is rated as a stock in the risk category Moderate. the annual standard deviation is 43.6%, which classifies the stock as Moderate.
Is Tenet Healthcare overvalued?
Tenet Healthcare is considered fairly valued – the price is close to the analyst price target. Tenet Healthcare has the following valuation ratios: a P/E ratio of 8.4 (lowly valued), a P/S ratio of 1.0, a P/B ratio of 4.3. The stock trades close to the analyst price target and is considered fairly valued.
Is Tenet Healthcare overbought?
No, Tenet Healthcare is not overbought. RSI is at 58.7 (neutral zone). The technical indicators show: RSI is at 58.7 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 3.4% above the 20-day average (short-term uptrend). In addition, MACD is positive with rising momentum (bullish).
When is the next Tenet Healthcare earnings report?
The date of the next earnings report for Tenet Healthcare has not been published yet. Check the company's investor calendar for updates.
Is Tenet Healthcare shorted?
Yes, Tenet Healthcare is shorted with 2.6% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying Tenet Healthcare stock?
No, insiders are not buying Tenet Healthcare shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 7 sales. On a net basis, 40,489,234 USD worth of shares were sold. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 62,450,491 USD sold. Active sellers include KERREY J ROBERT, MARK RICHARD J, West Nadja and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Tenet Healthcare a good stock?
Based on our total score, Tenet Healthcare is rated as a fantastic stock with a total score of 86 out of 100. The stock scores exceptionally high on value, quality and momentum. The score is made up of Value: 84/100, Quality: 82/100, Momentum: 92/100. Whether now is the time to buy is a separate question: the technical signal is Strong Buy. Whether Tenet Healthcare is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Tenet Healthcare stock?
The outlook for Tenet Healthcare based on current data: the average analyst price target is $306.18 (+7.0%); the stock is in an uptrend (above SMA50 and SMA200); the P/E ratio is 8.4 (low – a possible value stock). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Tenet Healthcare stock rising?
Tenet Healthcare is rising right now. The technical indicators show: the price is 3.4% above the 20-day average; MACD is positive with rising momentum (bullish signal); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can Tenet Healthcare go?
The average analyst price target for Tenet Healthcare is $306.18, which corresponds to a potential gain of 7.0% from the current price of $286.03. The stock has traded between $157.58 and $301.44 over the last 52 weeks. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Tenet Healthcare fall?
The stock has traded as low as $157.58 over the last 52 weeks — that is 44.9% below the current price of $286.03. The biggest decline (drawdown) in the same period was 47.7% from high to low. Within a year, the price typically swings about ±43.6% (standard deviation — a measure of price swings). A difficult year could therefore mean a further decline of that size. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Tenet Healthcare do?
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery ro... The company belongs to the Healthcare sector, more specifically the Medical Care Facilities industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Tenet Healthcare as an investment.
Did Tenet Healthcare raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Tenet Healthcare. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is Tenet Healthcare making money or losing money?
Yes, Tenet Healthcare is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 13.1% — which is solid. The operating margin (profit before interest and taxes) is 19.1%. At a P/E ratio of 8.4, you currently pay 8.4 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Tenet Healthcare go bankrupt?
The bankruptcy risk of Tenet Healthcare is rated as low. Altman Z2 (a model for assessing financial distress) is 2.69 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 8 — which is strong. Debt relative to equity is 489% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Tenet Healthcare have a lot of debt?
Yes, Tenet Healthcare has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 489%. For the healthcare sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. In healthcare, 80-150% is typical — large pharma companies carry debt for research and acquisitions. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can Tenet Healthcare service its debt? Can service its debt without problems — the interest coverage ratio (how many times earnings can cover interest payments) is 8.8x, and net debt equals 2.1 years of earnings (EBITDA).